GRIFOLS | GRF - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Alcon AG USD 2.78B 370M 2026-06
Almirall EUR 531.16M 13.76M 2026-06
Amadeus IT EUR 1.17B 17.5M 2026-06
Amarin USD 51.48M 113K 2025-12
argenx SE USD 1.02B 118M 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Bayer EUR 10.04B 168M 2026-06
Cie Automotive EUR 1.69B 20.74M 2025-12
Demant DKK 10.79B 1.16B 2026-06
Ence Energia y Celulosa EUR 188.7M 35.73M 2026-03
Essilor EUR 12.52B 568M 2026-06
Ferrovial EUR 4.21B 412M 2026-06
Fresenius EUR 5.23B 9M 2026-06
Fresenius Medical Care EUR 4.32B 20.7M 2026-06
Genmab DKK 748M 77M 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Inditex EUR 6.99B 2.64B 2026-03
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Merck EUR 4.34B 249M 2026-06
Novartis USD 10.2B 912M 2026-06
Philips EUR 3.75B 147M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
Smith & Nephew USD 2.59B 71M 2026-06
UCB EUR 2.96B 196M 2025-12
Viscofan EUR 275.44M 12.84M 2026-06